Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06870357Phase 1Completed
Phase 1, open-label trial of propofol injection (veterinary) (2 arms), sponsored by The Second Hospital of Shanxi Medical University. Primary endpoints: Telomere Length at 24 hours, Time to Loss of Consciousness at 24 hours and 6 more. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06870357.